29.09.2023 15:22:25

EQS-CMS: SCHOTT Pharma AG & Co. KGaA: Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

EQS Post-admission Duties announcement: SCHOTT Pharma AG & Co. KGaA / Home Member State
SCHOTT Pharma AG & Co. KGaA: Release of the Home Member State according to Article 5 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution

29.09.2023 / 15:22 CET/CEST
Dissemination of a Post-admission Duties announcement transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.


SCHOTT Pharma AG & Co. KGaA announces according to Art. 5 WpHG that Germany is the Home Member State.


29.09.2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.eqs-news.com


Language: English
Company: SCHOTT Pharma AG & Co. KGaA
Hattenbergstraße 10
55122 Mainz
Germany

 
End of News EQS News Service

1738411  29.09.2023 CET/CEST

fncls.ssp?fn=show_t_gif&application_id=1738411&application_name=news&site_id=smarthouse

Analysen zu SCHOTT Pharmamehr Analysen

03.01.25 SCHOTT Pharma Hold Jefferies & Company Inc.
16.12.24 SCHOTT Pharma Hold Joh. Berenberg, Gossler & Co. KG (Berenberg Bank)
13.12.24 SCHOTT Pharma Verkaufen DZ BANK
13.12.24 SCHOTT Pharma Buy Deutsche Bank AG
12.12.24 SCHOTT Pharma Hold Jefferies & Company Inc.
Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

SCHOTT Pharma 24,28 -1,06% SCHOTT Pharma